{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["62(9)"],"submitter":["Neumann A"],"pubmed_abstract":["<h4>Introduction</h4>Lung cancer is the most common cancer worldwide. Every year, as many people die of lung cancer as of breast, colon and rectum cancers combined. Because most patients are being diagnosed in advanced, not resectable stages and therefore have a poor prognosis, there is an urgent need for alternative therapies. Since it has been demonstrated that a high number of tumor- and stromal-infiltrating cytotoxic T cells (CTLs) is associated with an increased disease-specific survival in lung cancer patients, it can be assumed that immunotherapy, e.g. peptide vaccines that are able to induce a CTL response against the tumor, might be a promising approach.<h4>Methods</h4>We analyzed surgically resected lung cancer tissues with respect to HLA class I- and II-presented peptides and ge"],"journal":["Cancer immunology, immunotherapy : CII"],"pagination":["1485-97"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11028602"],"repository":["biostudies-literature"],"pubmed_title":["Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer."],"pmcid":["PMC11028602"],"pubmed_authors":["Aebert H","Rammensee HG","Horzer H","Stevanovic S","Neumann A","Hillen N","Klingel K","Schmid-Horch B","Buhring HJ"],"additional_accession":[]},"is_claimable":false,"name":"Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer.","description":"<h4>Introduction</h4>Lung cancer is the most common cancer worldwide. Every year, as many people die of lung cancer as of breast, colon and rectum cancers combined. Because most patients are being diagnosed in advanced, not resectable stages and therefore have a poor prognosis, there is an urgent need for alternative therapies. Since it has been demonstrated that a high number of tumor- and stromal-infiltrating cytotoxic T cells (CTLs) is associated with an increased disease-specific survival in lung cancer patients, it can be assumed that immunotherapy, e.g. peptide vaccines that are able to induce a CTL response against the tumor, might be a promising approach.<h4>Methods</h4>We analyzed surgically resected lung cancer tissues with respect to HLA class I- and II-presented peptides and ge","dates":{"release":"2013-01-01T00:00:00Z","publication":"2013 Sep","modification":"2025-04-22T20:43:39.629Z","creation":"2025-04-06T03:14:39.697Z"},"accession":"S-EPMC11028602","cross_references":{"pubmed":["23817722"],"doi":["10.1007/s00262-013-1454-2"]}}